Liver transplantation with use of cyclosporin a and prednisone.

PubWeight™: 6.95‹?› | Rank: Top 1%

🔗 View Article (PMC 2772056)

Published in N Engl J Med on July 30, 1981

Authors

T E Starzl, G B Klintmalm, K A Porter, S Iwatsuki, G P Schröter

Articles citing this

Evolution of liver transplantation. Hepatology (1982) 19.54

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21

Cardiac transplantation with cyclosporin A and prednisone. Ann Surg (1982) 2.21

Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc (1985) 1.98

Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics (1984) 1.86

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Current status of hepatic transplantation. Semin Liver Dis (1983) 1.75

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73

Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg (2001) 1.66

Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66

Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62

Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61

IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ (2013) 1.56

Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54

Acute and chronic renal failure in liver transplantation. Nephron (1990) 1.52

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease. Transplant Proc (1983) 1.36

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

Human polymorphonuclear leukocyte interaction with cyclosporine A. Infect Immun (1984) 1.27

Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14

Renal failure in children with hepatic failure undergoing liver transplantation. J Pediatr (1986) 1.14

Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09

Liver transplantation for biliary atresia. World J Surg (1984) 1.09

CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry (1993) 1.07

Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol (1987) 1.07

Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr Mol Pharmacol (2010) 1.06

Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorg Med Chem (2010) 1.04

Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother (2009) 1.03

Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer (2012) 0.99

Themes of liver transplantation. Hepatology (2010) 0.98

Cyclosporine and its metabolites in mother and baby. Transplantation (1988) 0.97

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96

99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology (1982) 0.95

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Effect of bile on cyclosporine absorption in dogs. Res Commun Chem Pathol Pharmacol (1986) 0.93

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl (2001) 0.93

Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg (1989) 0.92

Pediatric liver transplantation. World J Gastroenterol (2009) 0.92

Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg (1994) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun (1983) 0.89

Renal injury induced by long-term administration of cyclosporin A to rats. Am J Pathol (1987) 0.88

Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. Transplant Proc (1983) 0.88

Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med (2014) 0.87

A comprehensive review of immunosuppression used for liver transplantation. J Transplant (2009) 0.86

Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc (1987) 0.86

Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg (1986) 0.86

Renal dysfunction associated with liver transplantation. Postgrad Med J (1995) 0.83

Liver transplantation for primary biliary cirrhosis. Semin Liver Dis (1989) 0.83

Macrocyclic inhibitors of hsp90. Curr Top Med Chem (2010) 0.83

Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation. Clin Dev Immunol (2013) 0.83

Early results of cardiac transplantation at the Texas Heart Institute. Thorax (1984) 0.82

Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc (2003) 0.82

Extraction ratio of cyclosporine in a liver transplant patient with organ rejection. J Pharm Sci (1985) 0.81

Living donor liver transplantation: Eastern experiences. HPB (Oxford) (2004) 0.81

Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation. Transplantation (1989) 0.81

Divalent cation signaling in immune cells. Trends Immunol (2014) 0.80

Liver transplantation: current concepts. CMAJ (1988) 0.79

Overview of clinical lung transplantation. Cold Spring Harb Perspect Med (2014) 0.79

Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis. PLoS One (2014) 0.79

Cardiac transplantation with the use of cyclosporin a for immunologic suppression. Tex Heart Inst J (1982) 0.79

Impact of early reoperation following living-donor liver transplantation on graft survival. PLoS One (2014) 0.78

Liver transplantation for malignancy: current treatment strategies and future perspectives. World J Gastroenterol (2014) 0.78

Q-FISH measurement of hepatocyte telomere lengths in donor liver and graft after pediatric living-donor liver transplantation: donor age affects telomere length sustainability. PLoS One (2014) 0.78

Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils. Eur J Clin Pharmacol (1993) 0.77

The long reach of liver transplantation. Nat Med (2012) 0.77

A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. J Clin Invest (2012) 0.76

Liver transplantation for hepatitis C virus related liver disease. Postgrad Med J (2005) 0.76

Historical overview of transplantation. Cold Spring Harb Perspect Med (2013) 0.76

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

The clearance of cyclosporine by hemodialysis. J Clin Pharmacol (1985) 0.75

The ascension of clinical organ transplantation. Transplant Proc (1999) 0.75

Steroid metabolism in liver transplant patients. Transplant Proc (1989) 0.75

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75

Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action. J Med Chem (2009) 0.75

The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75

Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75

Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative management. Radiology (1985) 0.75

The transplantation of gastrointestinal organs. Gastroenterology (1993) 0.75

Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 1: effects of cleavage conditions and N-terminal functionality. Biopolymers (2011) 0.75

Opportunities and costs of clinical research. Semin Liver Dis (1985) 0.75

Diurnal variation in cyclosporine kinetics. Ther Drug Monit (1986) 0.75

Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis (1998) 0.75

Giving and taking: the family doctor and organ transplantation. Can Fam Physician (1983) 0.75

Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16